Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP894302.RAKb9xCSPqGlwp-LiSrFEU5OTS3MOYYc_NTTefWhWgg_M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP894302.RAKb9xCSPqGlwp-LiSrFEU5OTS3MOYYc_NTTefWhWgg_M130_assertion type Assertion NP894302.RAKb9xCSPqGlwp-LiSrFEU5OTS3MOYYc_NTTefWhWgg_M130_head.
- NP894302.RAKb9xCSPqGlwp-LiSrFEU5OTS3MOYYc_NTTefWhWgg_M130_assertion wasGeneratedBy ECO_0000203 NP894302.RAKb9xCSPqGlwp-LiSrFEU5OTS3MOYYc_NTTefWhWgg_M130_provenance.
- NP894302.RAKb9xCSPqGlwp-LiSrFEU5OTS3MOYYc_NTTefWhWgg_M130_assertion wasDerivedFrom befree-20140225 NP894302.RAKb9xCSPqGlwp-LiSrFEU5OTS3MOYYc_NTTefWhWgg_M130_provenance.
- NP894302.RAKb9xCSPqGlwp-LiSrFEU5OTS3MOYYc_NTTefWhWgg_M130_assertion SIO_000772 19195606 NP894302.RAKb9xCSPqGlwp-LiSrFEU5OTS3MOYYc_NTTefWhWgg_M130_provenance.
- NP894302.RAKb9xCSPqGlwp-LiSrFEU5OTS3MOYYc_NTTefWhWgg_M130_assertion evidence source_evidence_literature NP894302.RAKb9xCSPqGlwp-LiSrFEU5OTS3MOYYc_NTTefWhWgg_M130_provenance.
- NP894302.RAKb9xCSPqGlwp-LiSrFEU5OTS3MOYYc_NTTefWhWgg_M130_assertion description "[After stimulation with TLR2 and TLR4 agonists, AVICs express higher levels of pro-inflammatory and pro-osteogenic mediators (bone morphogenetic protein [BMP]-2, runt-related transcription factor 2) and greater osteogenic phenotypic changes (alkaline phosphatase [ALP] activity, calcified nodule formation) than PVICs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP894302.RAKb9xCSPqGlwp-LiSrFEU5OTS3MOYYc_NTTefWhWgg_M130_provenance.